Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Wegovy Lawsuit Alleges Vision Loss Side Effects Concealed by Novo Nordisk After just one year of using the popular weight loss drug, an Illinois man experienced vision loss side effects from Wegovy, resulting in a diagnosis of NAION. May 6, 2025 Irvin Jackson Add Your Comments An Illinois man’s Wegovy lawsuit claims that side effects from the popular weight loss drug caused him to develop permanent vision problems, which could have been avoided if the medication carried proper label warnings. The complaint (PDF) was filed by Kirk Osterman in the U.S. District Court for the District of New Jersey on April 29, naming Novo Nordisk, Wegovy’s manufacturer, and its subsidiaries as the defendants. Wegovy (semaglutide) is a higher-dose formulation of the diabetes drug Ozempic, and both belong to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1RAs). While Ozempic is only approved for the treatment of type 2 diabetes, it has been widely used off-label for weight loss. In response to this growing demand, Novo Nordisk introduced Wegovy in June 2021, using the same active ingredient specifically for weight management. Wegovy Vision Loss Side Effects In recent months, concerns have grown over the side effects of Wegovy, Ozempic and other GLP-1 medications, particularly related to serious gastrointestinal issues such as gastroparesis, ileus and intestinal blockages. However, new concerns about Wegovy vision loss side effects emerged in July 2024, after a study was published by Harvard researchers that found patients using semaglutide may face seven times the risk of a rare eye condition, known as non-arteritic anterior ischemic optic neuropathy (NAION), where the optic nerve suffers from insufficient blood flow. The condition can cause sudden vision changes, blurred sight and even blindness. These findings appeared to be confirmed by a study published in medRxiv in January, which led the Danish Medicines Agency to issue a press release days later, announcing that it is officially requesting an investigation into Ozempic and Wegovy NAION risks by the European Pharmacovigilance Risk Assessment Committee (PRAC). Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION In his lawsuit, Osterman indicates he was first prescribed Wegovy for weight loss in June 2023, and continued to take regular injections for about a year. As a result, Osterman’s complaint states that he developed NAION, leading to blurred vision and some vision loss in his right eye. According to the complaint, the situation is made worse by the fact that Wegovy-induced weight loss is not sustainable without ongoing use of the drug. As a result, users must continue taking the medication, and potentially face an increased risk of vision loss, just to maintain the weight they’ve lost. “Defendants knew, or should have known, based on preclinical trials, premarket clinical trials, post-market surveillance, and adverse event reports of NAION injuries with Wegovy or semaglutide drugs that there was reasonable evidence of a causal association between the use of Wegovy and NAION,” the lawsuit states. “Despite this, Defendants failed to warn about the risk of NAION with Wegovy.” Osterman presents claims of failure to warn, breach of warranty, fraudulent concealment by omission, fraudulent/intentional misrepresentation, negligent misrepresentation/marketing, negligent design, design defect, negligence, and negligent undertaking. He seeks compensatory and punitive damages. Wegovy and GLP-1 Stomach Paralysis Lawsuits While recent filings of NAION vision loss lawsuits linked to Wegovy and Ozempic are on the rise, most of the focus has been on thousands of gastroparesis lawsuits brought by former user of the medications, each presenting similar allegations that users were left with the painful and debilitating stomach problems, also known as stomach paralysis. Plaintiffs in these cases argue that debilitating gastrointestinal side effects could have been avoided if the drug makers had not placed profits over patient safety, and provided false and misleading information to patients and the medical community. Given common questions of fact and law raised in Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits filed throughout the federal court system, a Multidistrict Litigation (MDL) has been established before U.S. District Judge Karen S. Marston in the Eastern District of Pennsylvania. Judge Marston is presiding over coordinated discovery and pretrial proceedings to prepare a small group of cases for early trial dates. However, before scheduling the first bellwether trials, the parties have been tasked with addressing a number of “cross-cutting” issues, including whether claims are preempted by federal law, whether plaintiffs are required to present specific diagnostic testing evidence to substantiate their injuries, and whether there is sufficient general causation evidence linking Ozempic and the gastrointestinal injuries. While the outcomes of these early test cases will not be binding on other claims, they will be closely watched and may help the parties negotiate GLP-1 settlements to resolve large numbers of lawsuits in the future. Tags: Blindness, Blurry Vision, Diabetes, Diabetes Drug, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Vision, Vision Loss, Wegovy, Weight Loss, Zepbound Image Credit: Shutterstock – KK Stock More Ozempic, Wegovy and Mounjaro Stories Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis June 13, 2025 Ozempic NAION Side Effects Result in Vision Loss Warnings by European Regulators June 9, 2025 Ozempic Lawsuit Alleges Woman Experienced Severe Bowel Obstruction Injuries June 3, 2025 Find Out If You Qualify for Ozempic or Wegovy Compensation 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: today) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025) Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 3 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025) Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: 4 days ago) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: today) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)
Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 3 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025)
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: 4 days ago) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)